CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
328.11
1.07%
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.31
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Humana Inc ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 324.63
Open* 327.61
1-Year Change* -36.03%
Day's Range* 327.07 - 329.49
52 wk Range 390.50-541.21
Average Volume (10 days) 2.45M
Average Volume (3 months) 32.66M
Market Cap 50.72B
P/E Ratio 17.08
Shares Outstanding 123.11M
Revenue 102.35B
EPS 24.12
Dividend (Yield %) 0.85927
Beta 0.48
Next Earnings Date Jan 25, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 19, 2024 328.11 4.50 1.39% 323.61 329.64 323.61
Apr 18, 2024 324.63 1.52 0.47% 323.11 330.24 323.11
Apr 17, 2024 323.09 4.43 1.39% 318.66 323.96 318.04
Apr 16, 2024 317.23 -9.60 -2.94% 326.83 328.52 317.20
Apr 15, 2024 314.33 -0.62 -0.20% 314.95 317.42 311.74
Apr 12, 2024 312.18 -2.77 -0.88% 314.95 315.72 309.57
Apr 11, 2024 316.06 -2.28 -0.72% 318.34 320.06 315.08
Apr 10, 2024 318.90 4.80 1.53% 314.10 321.04 314.10
Apr 9, 2024 319.24 5.24 1.67% 314.00 319.48 313.95
Apr 8, 2024 316.75 6.37 2.05% 310.38 318.70 310.22
Apr 5, 2024 312.73 7.50 2.46% 305.23 314.06 305.22
Apr 4, 2024 309.89 1.11 0.36% 308.78 314.26 306.61
Apr 3, 2024 308.00 3.10 1.02% 304.90 312.54 301.76
Apr 2, 2024 304.02 -7.94 -2.55% 311.96 319.85 299.17
Apr 1, 2024 351.21 5.26 1.52% 345.95 352.83 345.27
Mar 28, 2024 346.07 -3.65 -1.04% 349.72 350.55 345.70
Mar 27, 2024 349.23 0.79 0.23% 348.44 350.94 347.25
Mar 26, 2024 348.11 1.61 0.46% 346.50 350.14 345.99
Mar 25, 2024 346.84 -2.12 -0.61% 348.96 349.14 345.42
Mar 22, 2024 348.34 1.46 0.42% 346.88 353.68 346.73

Humana Events

Time (UTC) Country Event
Wednesday, April 24, 2024

Time (UTC)

12:30

Country

US

Event

Q1 2024 Humana Inc Earnings Release
Q1 2024 Humana Inc Earnings Release

Forecast

-

Previous

-

Time (UTC)

13:00

Country

US

Event

Q1 2024 Humana Inc Earnings Call
Q1 2024 Humana Inc Earnings Call

Forecast

-

Previous

-
Thursday, August 1, 2024

Time (UTC)

13:00

Country

US

Event

Q2 2024 Humana Inc Earnings Call
Q2 2024 Humana Inc Earnings Call

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 92870 83064 77155 64888 56912
Total Operating Expense 88833 79916 72169 61696 54598
Depreciation / Amortization 709 596 489 458 405
Unusual Expense (Income) 116 128 0 0 786
Other Operating Expenses, Total 12318 9993 10052 7145 7525
Operating Income 4037 3148 4986 3192 2314
Interest Income (Expense), Net Non-Operating -401 -326 -283 -242 -218
Net Income Before Taxes 3568 3354 4600 3456 2063
Net Income After Taxes 2806 2869 3293 2693 1711
Net Income Before Extra. Items 2806 2933 3367 2707 1722
Net Income 2806 2933 3367 2707 1683
Income Available to Common Excl. Extra. Items 2806 2933 3367 2707 1722
Income Available to Common Incl. Extra. Items 2806 2933 3367 2707 1683
Diluted Net Income 2806 2933 3367 2707 1683
Diluted Weighted Average Shares 127.094 129.396 133.012 134.727 138.403
Diluted EPS Excluding Extraordinary Items 22.0781 22.6668 25.3135 20.0925 12.4419
Dividends per Share - Common Stock Primary Issue 3.15 2.8 3.05 2.15 1.9
Diluted Normalized EPS 22.7959 23.513 25.3135 20.0925 17.152
Total Premiums Earned 92488 82877 76001 64387 56398
Net Investment Income 382 187 1154 501 514
Losses, Benefits, and Adjustments, Total 75690 69199 61628 53857 45882
Total Extraordinary Items 0 -39
Other, Net -68 532 -103 506 -33
Equity In Affiliates -4 65 74 14 11
Selling/General/Admin. Expenses, Total 236
Minority Interest 4 -1
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 26747 26742 22439 22799 23662
Total Operating Expense 25311 25023 22318 21387 22447
Depreciation / Amortization 191 186 182 182 175
Other Operating Expenses, Total 3107 3030 3412 3040 2997
Operating Income 1436 1719 121 1412 1215
Interest Income (Expense), Net Non-Operating -120 -113 -108 -102 -101
Other, Net -54 8 -84 -13 8
Net Income Before Taxes 1262 1614 -71 1297 1122
Net Income After Taxes 966 1255 -13 1190 695
Equity In Affiliates -10 -17 -5 3 2
Net Income Before Extra. Items 959 1239 -15 1195 696
Net Income 959 1239 -15 1195 696
Income Available to Common Excl. Extra. Items 959 1239 -15 1195 696
Income Available to Common Incl. Extra. Items 959 1239 -15 1195 696
Diluted Net Income 959 1239 -15 1195 696
Diluted Weighted Average Shares 125.109 125.564 125.642 127.356 127.084
Diluted EPS Excluding Extraordinary Items 7.66532 9.86748 -0.11939 9.38315 5.47669
Dividends per Share - Common Stock Primary Issue 0.885 0.885 0.7875 0.7875 0.7875
Diluted Normalized EPS 7.68979 9.55165 0.61524 7.80542 6.33455
Total Premiums Earned 26473 26549 22279 22627 23615
Net Investment Income 274 193 160 172 47
Losses, Benefits, and Adjustments, Total 22009 21858 18582 18384 19099
Unusual Expense (Income) 4 -51 142 -219 176
Minority Interest 3 1 3 2 -1
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Cash & Equivalents 5061 3394 4673 4054 2343
Total Assets 43055 44358 34969 29074 25413
Property/Plant/Equipment, Total - Net 3736 3751 2808 2365 1735
Property/Plant/Equipment, Total - Gross 6872 6625 5931 5025 4048
Accumulated Depreciation, Total -3136 -2874 -3123 -2660 -2313
Goodwill, Net 9142 11092 4447 3928 3897
Intangibles, Net 1765 2639 329 177 245
Long Term Investments 15010 14113 14936 12441 11484
Other Assets, Total 6667 7555 6638 5053 4694
Payable/Accrued 5086 4324 3884 3638 3067
Notes Payable/Short Term Debt 893 326 320 525 1466
Current Port. of LT Debt/Capital Leases 1497 1953 600 399 399
Other Current Liabilities, Total 286 254 318 247 283
Total Liabilities 27744 28278 21241 17037 15252
Total Long Term Debt 9034 10541 6060 4967 4375
Long Term Debt 9034 10541 6060 4967 4375
Other Liabilities, Total 1017 1837 1432 809 800
Total Equity 15311 16080 13728 12037 10161
Common Stock 33 33 33 33 33
Additional Paid-In Capital 3246 3082 2705 2820 2535
Retained Earnings (Accumulated Deficit) 25492 23086 20517 17483 15072
Treasury Stock - Common -12156 -10163 -9918 -8455 -7320
Other Equity, Total -1304 42 391 156 -159
Total Liabilities & Shareholders’ Equity 43055 44358 34969 29074 25413
Total Common Shares Outstanding 124.975 128.802 128.861 132.105 135.567
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Accrued Expenses 608 731 484 448
Minority Interest 59 23
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Cash & Equivalents 15148 16214 13735 5061 13558
Total Assets 55905 56455 54776 43055 50765
Property/Plant/Equipment, Total - Net 3342 3309 3234 3221 3218
Goodwill, Net 9540 9539 9320 9142 9096
Intangibles, Net 1765 1782 1754 1765 1797
Long Term Investments 16277 16373 16042 15010 14237
Other Assets, Total 8009 7809 7584 7182 7250
Payable/Accrued 7600 8118 7431 5238 6766
Notes Payable/Short Term Debt 2491 1304 832 893 540
Other Current Liabilities, Total 7536 7378 7220 286 6012
Total Liabilities 38956 39621 38199 27744 34511
Total Long Term Debt 9483 9722 9743 9034 7798
Long Term Debt 9483 9722 9743 9034 7798
Other Liabilities, Total 1595 1563 1457 1473 1599
Total Equity 16949 16834 16577 15311 16254
Common Stock 33 33 33 33 33
Additional Paid-In Capital 3362 3313 3262 3246 3234
Retained Earnings (Accumulated Deficit) 28191 27468 26619 25492 25606
Treasury Stock - Common -13134 -12754 -12224 -12156 -11152
Other Equity, Total -1503 -1226 -1113 -1304 -1467
Total Liabilities & Shareholders’ Equity 55905 56455 54776 43055 50765
Total Common Shares Outstanding 123.111 123.907 124.945 124.975 126.6
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 1175 1441 1497 2496
Minority Interest 55 57 57 59 63
Other Long Term Assets, Total
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 2802 2934 3367 2707 1683
Cash From Operating Activities 4587 2262 5639 5284 2173
Cash From Operating Activities 749 640 528 505 444
Amortization 96 73 88 70 90
Deferred Taxes -100 15 195 162 194
Non-Cash Items 231 -1014 107 149 948
Cash Taxes Paid 758 227 1132 518 631
Cash Interest Paid 354 285 258 212 195
Changes in Working Capital 809 -386 1354 1691 -1186
Cash From Investing Activities -1006 -6556 -3065 -1278 -3087
Capital Expenditures -1120 -1316 -964 -736 -612
Other Investing Cash Flow Items, Total 114 -5240 -2101 -542 -2475
Cash From Financing Activities -1914 3015 -1955 -2295 -785
Financing Cash Flow Items 1987 -337 -939 -623 -640
Total Cash Dividends Paid -392 -354 -323 -291 -265
Issuance (Retirement) of Stock, Net -2087 -58 -1771 -1012 -1045
Issuance (Retirement) of Debt, Net -1422 3764 1078 -369 1165
Net Change in Cash 1667 -1279 619 1711 -1699
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 1238 2802 2820 1627 930
Cash From Operating Activities 6687 4587 9714 1261 302
Cash From Operating Activities 200 749 555 369 181
Amortization 18 96 73 45 24
Non-Cash Items 55 231 76 235 47
Cash Taxes Paid 6 758 751 373 -20
Cash Interest Paid 97 354 256 171 67
Changes in Working Capital 5176 809 6223 -1182 -880
Cash From Investing Activities -1292 -1006 6 -1670 -648
Capital Expenditures -223 -1120 -862 -574 -295
Other Investing Cash Flow Items, Total -1069 114 868 -1096 -353
Cash From Financing Activities 3279 -1914 444 2235 1816
Financing Cash Flow Items 2887 1987 3785 3074 2474
Total Cash Dividends Paid -100 -392 -291 -191 -91
Issuance (Retirement) of Stock, Net -94 -2087 -1045 -1039 -1037
Issuance (Retirement) of Debt, Net 586 -1422 -2005 391 470
Net Change in Cash 8674 1667 10164 1826 1470
Deferred Taxes -100 -33 167

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Humana Company profile

About Humana Inc

Humana Inc. is a health and well-being company. The Company operates through three reportable segments: Retail, Group and Specialty, and Healthcare Services. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts. It also includes its contract to administer the limited income newly eligible transition (LI-NET), prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and long-term support services benefits. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only products. The Healthcare Services segment includes pharmacy, provider, and home services, along with other services and capabilities to promote wellness and population health.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Humana Inc revenues increased 8% to $83.06B. Net income decreased 13% to $2.93B. Revenues reflect Retail segment increase of 10% to $73.84B, Healthcare Services segment increase from $1.02B to $2.22B, Medical Expense Ratio -%-Employer Group decrease of 4% to 82.5%. Net income was offset by Eliminations/Corporate segment loss totaling $202M vs. income of $1.24B.

Equity composition

Common Stock $.16 2/3 Par, 3/11, 300M auth., 191,607,107 issd., less 23,212,730 shs. in Treas. @ $583.3M. Insiders owns approx. 0.57%. PO11/82, 3M shares @ $13.125 by Lehman Brothers Kuhn Loeb. *NOTE: 3/93, the acute care hospital division (Galen Health Care) was spun off. FY'99-'00 and FY'00-'01 Q's are reclassified.

Industry: Managed Healthcare (NEC)

500 W Main St
LOUISVILLE
KENTUCKY 40202
US

Income Statement

  • Annual
  • Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

People also watch

US100

17,163.90 Price
+0.770% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

ETH/USD

3,229.38 Price
+2.460% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Gold

2,357.43 Price
-1.480% 1D Chg, %
Long position overnight fee -0.0194%
Short position overnight fee 0.0111%
Overnight fee time 21:00 (UTC)
Spread 0.40

XRP/USD

0.54 Price
+2.110% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading